Dexcom (DC4) Q4 2024 Earnings Report
CH:DC4 Q4 2024 EPS Results
- Actual EPS
- CHF 0.37
- Consensus EPS
- CHF 0.40
- Beat/Miss
- Missed by -CHF 0.02
- One Year Ago EPS
- CHF 0.41
CH:DC4 Q4 2024 Revenue Results
- Actual Revenue
- CHF 918.42M
- Expected Revenue
- CHF 914.83M
- Beat/Miss
- Beat by +CHF 3.59M
- YoY Revenue Growth
- +7.64%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 02/13/2025
- Time
- After Close
- Conference Call
- Thursday, February 13, 2025
CH:DC4 Upcoming Earnings
Dexcom's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
CH:DC4 Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:DC4 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | 0.59- | 0.56 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.560.60 | 0.5 | 19.67% (+0.10) | |
| Jul 30, 2026 | 2026 (Q2) | 0.500.58 | 0.4 | 45.83% (+0.18) | |
| Apr 30, 2026 | 2026 (Q1) | 0.380.46 | 0.26 | 75.00% (+0.20) | |
| Feb 12, 2026 | 2025 (Q4) | 0.540.56 | 0.37 | 51.11% (+0.19) | |
| Oct 30, 2025 | 2025 (Q3) | 0.480.50 | 0.37 | 35.56% (+0.13) | |
| Jul 30, 2025 | 2025 (Q2) | 0.370.40 | 0.35 | 11.63% (+0.04) | |
| May 01, 2025 | 2025 (Q1) | 0.270.26 | 0.26 | 0.00% (+0.00) | |
| Feb 13, 2025 | 2024 (Q4) | 0.400.37 | 0.41 | -10.00% (-0.04) | |
| Oct 24, 2024 | 2024 (Q3) | 0.360.37 | 0.41 | -10.00% (-0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
